Yusys Technologies Co.Ltd(300674) february 28 disclosed the annual performance express of 2021. The company achieved an annual operating revenue of about 3.726 billion yuan, a year-on-year increase of 24.97%; The net profit attributable to the shareholders of the listed company was about 395 million yuan, a year-on-year decrease of 12.81%; The net profit attributable to shareholders of listed companies after deducting non recurring profits and losses was about 361 million yuan, a year-on-year increase of 22.21%.
The company said that thanks to the accelerated promotion of the national information technology application and innovation Shenzhen New Industries Biomedical Engineering Co.Ltd(300832) development strategy in the financial industry and the comprehensive implementation of the digital transformation of the banking industry, the company’s operating revenue continued to grow steadily. The comprehensive gross profit margin decreased slightly compared with the previous year, mainly due to the fierce competition for financial science and technology talents and the rise of labor costs in recent years. In the same period, the company continuously optimized its revenue structure and vigorously expanded innovative operations with high gross profit margin, laying a solid foundation and providing opportunities for the company’s long-term and high-quality development in the future.
In the new stage of high-quality development of the financial technology industry, the company relies on the competitive advantages of its main product lines such as credit, data, channels and supervision in the market. During the reporting period, the company’s software development and service revenue increased by 28.16% over the previous year. The growth of the company’s software development and service revenue mainly came from the increase of relevant business demand of large state-owned commercial banks; The innovative operation business of the company continued to maintain a rapid development momentum, and the innovative operation business revenue increased by 46.49% year-on-year.
During the reporting period, the company’s R & D investment increased by 38.83% over the previous year. The company took the R & D of new financial technology products as one of its key development strategies, continued to increase R & D investment, further improve the standardization of products, and consolidate the business leadership of new products, so as to maintain a continuous leading competitive advantage in medium and long-term development.
During the reporting period, the company’s refined management and digital management upgrading further improved the operation and management efficiency and reduced the management expense rate; The scale effect of the company reduces the company’s sales rate.
